![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » SENATOR SEEKS PROBE OF FDA, MERCK TIES
SENATOR SEEKS PROBE OF FDA, MERCK TIES
August 1, 2006
A U.S. senator has called for a probe of the U.S. Food and Drug Administration, saying the agency gave preferential treatment to Vioxx marketer Merck & Co. Senate Finance Chairman Charles Grassley, R-Iowa, says the FDA gave Merck notice before it let the public know that the popular pain drug was tied to increased risks of heart attack and stroke, CBS News reported.
UPI
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct